In his final earnings call with analysts Thursday, Vertex chief Jeffrey Leiden took a few moments to reflect on his eight-year tenure. Despite a run of success, Leiden’s final move as CEO could be one of his most successful: The
read moreNormally, a pharma company paying a patient to take its drug looks suspicious—like a kickback—and it’s considered so under federal law. But HHS has just made a special ruling that allows Novartis to pay for travel and other out-of-pocket expenses
read moreShire had big ambitions when it built a $400 million biologics plant in Ireland it said would help achieve its “ambition of becoming the world’s leading biotechnology company.” Well, Shire no longer exists. It was absorbed into Japan’s Takeda, which
read moreWith its Allergan merger likely in the final stages, AbbVie is placing its hopes in a pair of home-grown drugs to help weather biosimilar attacks against Humira. One of those, JAK inhibitor Rinvoq, just snagged a big win from England’s
read moreAbbVie’s HIV drug Kaletra and Gilead’s Ebola therapy remdesivir might work against the new coronavirus, Chinese scientists say. A Sanofi exec in South Korea was arrested in a vaccine bribery probe. Novartis aims to double its China sales in five
read moreThe UK is expected to officially leave the European Union at 11PM tonight, January 31st. More: 60% of UK unis expect Brexit to affect pharma industry relationships Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals